Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00901680 · ClinicalTrials.gov registry record
Creation of the BioBank, Early Detection and Discovery Biomarkers
A clinical trial of Breast Cancer and Pancreatic Cancer, sponsored by Corewell Health East.
- Completed
- Registry status
- 3,028
- Enrollment target
- 1
- Study location
NCT00901680: Completed study of Breast Cancer and Pancreatic Cancer, sponsored by Corewell Health East.
NCT00901680 is a study of Breast Cancer and Pancreatic Cancer that has completed, run by Corewell Health East. The registered enrollment target is 3,028 participants, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00901680, a study of Breast Cancer and Pancreatic Cancer, has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 3,028 participants
- Enrollment target
- 1
- Study location
Study Summary
To establish a multidisciplinary research structure for tissue repository that facilitates projects that bridge specialties that normally may or may not interact.
Conditions Studied
Study Locations (1)
Michigan
- William Beaumont Hospitals - Royal Oak
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,028 participants |
| Start Date | 2008-08 |
| Est. Completion | 2012-01 |
What the finished NCT00901680 record still lists
NCT00901680 is an observational study that tracks outcomes without assigning an intervention. Its 3,028 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT00901680 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT00901680 about?
NCT00901680 is a clinical study titled "Creation of the BioBank, Early Detection and Discovery Biomarkers". To establish a multidisciplinary research structure for tissue repository that facilitates projects that bridge specialties that normally may or may not interact.
What is the current status of trial NCT00901680?
This trial is currently completed. The enrollment target is 3,028 participants. The study started on 2008-08. Estimated completion is 2012-01.
What conditions does trial NCT00901680 study?
This clinical trial studies the following conditions: Breast Cancer, Pancreatic Cancer, Head and Neck Cancer.
Who is sponsoring clinical trial NCT00901680?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00901680 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00901680's enrollment target sits among peer trials
3,028 50th of 1224 higher than 1,175 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07116967 · 3,040 participants · Phase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- NCT00004847 · 3,000 participants · Phase 1
Diagnosis of Pheochromocytoma
- NCT00478712 · 3,000 participants
Hirschsprung Disease Genetic Study
- NCT00579566 · 3,000 participants
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia